Literature DB >> 1406628

Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

V B Kraus1, E Moran, J R Nevins.   

Abstract

Recent studies have shown that the adenovirus E1A12S product can trans-activate transcription by activating the transcription factor E2F. However, E2F cannot be the only target for the E1A12S product, since several cellular promoters have been found to be activated by the E1A12S protein even though they lack E2F sites. Indeed, we now show that activation of the hsp70 promoter by the E1A12S product requires the TATAA sequence. Moreover, activation of the hsp70 promoter requires the N-terminal domain of the E1A protein and does not require the conserved region 2 sequences which are required for the E2F-dependent activation of transcription. We conclude that the targeting of distinct transcription factors, leading to trans-activation of transcription of multiple promoters, involves distinct domains of the E1A proteins that are also required for oncogenic activity.

Mesh:

Substances:

Year:  1992        PMID: 1406628      PMCID: PMC360363          DOI: 10.1128/mcb.12.10.4391-4399.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 2.  TATA-binding protein is a classless factor.

Authors:  P A Sharp
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

3.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

4.  Distinct DNA targets for trans-activation by HTLV-1 tax and adenovirus E1A.

Authors:  J Nicholas; J R Nevins
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

5.  Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level.

Authors:  T Leff; R Elkaim; C R Goding; P Jalinot; P Sassone-Corsi; M Perricaudet; C Kédinger; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

7.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

8.  Transcription from a TATA-less promoter requires a multisubunit TFIID complex.

Authors:  B F Pugh; R Tjian
Journal:  Genes Dev       Date:  1991-11       Impact factor: 11.361

9.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

Authors:  S H Devoto; M Mudryj; J Pines; T Hunter; J R Nevins
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  Expression of early adenovirus genes requires a viral encoded acidic polypeptide.

Authors:  R P Ricciardi; R L Jones; C L Cepko; P A Sharp; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  31 in total

1.  A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.

Authors:  E Veal; M Eisenstein; Z H Tseng; G Gill
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

2.  TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.

Authors:  X Shen; P P Hu; N T Liberati; M B Datto; J P Frederick; X F Wang
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

3.  E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP.

Authors:  D Trouche; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.

Authors:  E J Kilbourne; M J Evans; S K Karathanasis
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

5.  The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation.

Authors:  K Sollerbrant; G Chinnadurai; C Svensson
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

6.  Adenovirus mediated-gene transfer into cardiomyocytes.

Authors:  L A Kirshenbaum
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

7.  Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function.

Authors:  Zhiping Zhang; Christina T Teng
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

8.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Oncogenic capacity of the E2F1 gene.

Authors:  D G Johnson; W D Cress; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain.

Authors:  A C Ström; P Ohlsson; G Akusjärvi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.